{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:23:55Z","timestamp":1773289435794,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009880","name":"Lazio Region","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009880","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006692","name":"University of Turin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006692","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Health to the Piemonte Region","award":["GR-2011-02348356"],"award-info":[{"award-number":["GR-2011-02348356"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.cancergen.2016.07.002","type":"journal-article","created":{"date-parts":[[2016,7,19]],"date-time":"2016-07-19T14:05:10Z","timestamp":1468937110000},"page":"381-387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Mesothelioma families without inheritance of a BAP1 predisposing mutation"],"prefix":"10.1016","volume":"209","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7530-4832","authenticated-orcid":false,"given":"Valeria","family":"Ascoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0313-9799","authenticated-orcid":false,"given":"Ilaria","family":"Cozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Vatrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Izzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Giorcelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Carnovale-Scalzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia Rosalba","family":"Grillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Facciolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Visca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Papotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisella","family":"Righi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2016.07.002_bib0010","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/PAT.0b013e32835d0efb","article-title":"Tumours associated with BAP1 mutations","volume":"45","author":"Murali","year":"2013","journal-title":"Pathology"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0015","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1158\/1078-0432.CCR-11-2375","article-title":"New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment","volume":"18","author":"Ladanyi","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0020","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jmedgenet-2011-100156","article-title":"Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers","volume":"48","author":"Abdel-Rahman","year":"2011","journal-title":"J Med Genet"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0025","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0030","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1479-5876-10-179","article-title":"BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs","volume":"10","author":"Carbone","year":"2012","journal-title":"J Transl Med"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0035","doi-asserted-by":"crossref","first-page":"e337","DOI":"10.1200\/JCO.2011.41.2965","article-title":"Toward an improved definition of the tumor spectrum associated with BAP1 germline mutations","volume":"30","author":"Wiesner","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0040","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/pcmr.12006","article-title":"A cryptic BAP1 splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma","volume":"25","author":"Wadt","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0045","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1093\/annonc\/mdt135","article-title":"Well-differentiated papillary mesothelioma: clustering in a Portuguese family with a germline BAP1 mutation","volume":"24","author":"Ribeiro","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0050","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ajhg.2013.04.012","article-title":"Germline BAP1 mutations predispose to renal cell carcinomas","volume":"92","author":"Popova","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0055","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/gcc.22218","article-title":"Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area","volume":"54","author":"Betti","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0060","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/gcc.22129","article-title":"Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases","volume":"53","author":"Pilarski","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0065","article-title":"Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases","author":"Rai","year":"2015","journal-title":"Clin Genet"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0070","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/cge.12472","article-title":"Germline BAP1 mutations predispose also to multiple basal cell carcinomas","volume":"88","author":"de la Fouchardiere","year":"2015","journal-title":"Clin Genet"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0075","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40364-015-0040-5","article-title":"BAP1 hereditary cancer predisposition syndrome: a case report and review of literature","volume":"3","author":"Klebe","year":"2015","journal-title":"Biomark Res"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0080","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.canlet.2015.09.011","article-title":"Germline BAP1 mutation in a family with high incidence of multiple primary cancers and a potential gene-environment interaction","volume":"369","author":"Cheung","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005633","article-title":"Combined genetic and genealogic studies uncover a large BAP1 cancer syndrome kindred tracing back nine generations to a common ancestor from the 1700s","volume":"11","author":"Carbone","year":"2015","journal-title":"PLoS Genet"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0090","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/cge.12501","article-title":"A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma","volume":"88","author":"Wadt","year":"2015","journal-title":"Clin Genet"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0095","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.gene.2015.03.031","article-title":"Absence of germline mutations in BAP1 in sporadic cases of malignant mesothelioma","volume":"563","author":"Sneddon","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0100","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.cancergen.2015.07.004","article-title":"An asbestos-exposed family with multiple cases of pleural malignant mesothelioma without inheritance of a predisposing BAP1 mutation","volume":"208","author":"Cheung","year":"2015","journal-title":"Cancer Genet"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0105","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.humpath.2015.06.024","article-title":"BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma","volume":"46","author":"McGregor","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0110","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/0008-5472.CAN-14-1008","article-title":"Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma","volume":"75","author":"Guo","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0115","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.lungcan.2014.10.017","article-title":"Prevalence of BRCA-1 associated protein 1 germline mutation in sporadic malignant pleural mesothelioma cases","volume":"87","author":"Rusch","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0120","article-title":"Germline BAP1 mutational landscape of asbestos-exposed malignant mesothelioma patients with family history of cancer","author":"Ohar","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0125","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.855","article-title":"The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma","volume":"43","author":"Bott","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0130","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1349-7006.2012.02223.x","article-title":"Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma","volume":"103","author":"Yoshikawa","year":"2012","journal-title":"Cancer Sci"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0135","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/JTO.0000000000000471","article-title":"High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma","volume":"10","author":"Nasu","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0140","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/JTO.0000000000000436","article-title":"Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study","volume":"10","author":"Lo Iacono","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0145","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/jhg.2015.91","article-title":"Frequent genomic rearrangements of BRCA1 associated protein-1 (BAP1) gene in Japanese malignant mesothelioma-characterization of deletions at exon level","volume":"60","author":"Emi","year":"2015","journal-title":"J Hum Genet"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0150","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0155","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.canep.2014.02.014","article-title":"Familial malignant mesothelioma: a population-based study in central Italy (1980\u20132012)","volume":"38","author":"Ascoli","year":"2014","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0160","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10689-016-9865-9","article-title":"Germline BAP1 mutations misreported as somatic based on tumor-only testing","volume":"15","author":"Abdel-Rahman","year":"2016","journal-title":"Fam Cancer"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0165","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1001\/jamadermatol.2015.1701","article-title":"Multiple cutaneous melanomas and clinically atypical moles in a patient with a novel germline BAP1 mutation","volume":"151","author":"Gerami","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0170","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/ng.910","article-title":"Germline mutations in BAP1 predispose to melanocytic tumors","volume":"43","author":"Wiesner","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035295","article-title":"Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families","volume":"7","author":"Njauw","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0180","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/gcc.22035","article-title":"Hereditary uveal melanoma: a report of a germline mutation in BAP1","volume":"52","author":"Hoiom","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0185","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cancergen.2013.05.018","article-title":"Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma","volume":"206","author":"Cheung","year":"2013","journal-title":"Cancer Genet"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0190","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1158\/1541-7786.MCR-13-0111","article-title":"A novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinoma","volume":"11","author":"Farley","year":"2013","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0195","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.molcel.2014.03.002","article-title":"Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O","volume":"54","author":"Mashtalir","year":"2014","journal-title":"Mol Cell"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0200","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/cas.12698","article-title":"Functional differences between wild-type and mutant-type BRCA1-associated protein 1 tumor suppressor against malignant mesothelioma cells","volume":"106","author":"Hakiri","year":"2015","journal-title":"Cancer Sci"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0205","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/modpathol.2015.65","article-title":"BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations","volume":"28","author":"Cigognetti","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0210","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1073\/pnas.1525735113","article-title":"Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma","volume":"113","author":"Bi","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0215","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/path.2784","article-title":"The role of mutant p53 in human cancer","volume":"223","author":"Goh","year":"2011","journal-title":"J Pathol"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0220","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/94.3.205","article-title":"Dominant negative ATM mutations in breast cancer families","volume":"94","author":"Chenevix-Trench","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0225","doi-asserted-by":"crossref","first-page":"34179","DOI":"10.1074\/jbc.M109.046755","article-title":"The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1","volume":"284","author":"Machida","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cancergen.2016.07.002_bib0230","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.canlet.2016.05.011","article-title":"CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma","volume":"378","author":"Betti","year":"2016","journal-title":"Cancer Lett"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776216302216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776216302216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:41:28Z","timestamp":1761896488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776216302216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S2210776216302216"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2016.07.002","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesothelioma families without inheritance of a BAP1 predisposing mutation","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2016.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}